3篇
您的检索式：作者名="Xingbang Li"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A Soft Bionic Gripper with Variable Effective Length显示文摘 | Yufei Hao Zheyuan Gong Zhexin Xie Shaoya Guan Xingbang Yang Tianmiao Wang Li Wen | 2018 | Journal of Bionic Engineering2018，15，2： | 12 |
| 2 | Metalloporphyrin-dioxygen interactions and the effects of neutral axial ligands显示文摘 | Sun Yong Hu Xingbang Li Haoran | 2009 | J Phys Chem C2009，113，14： | 1 |
| 3 | Safety and Efficacy of Biodegradable Patent Foramen Ovale Occluder in Patients with Migraine:A Clinical Trial显示文摘Background:Transcatheter closure of patent foramen ovale(PFO)has been widely accepted as a highly effective way to treat high-risk PFO-related diseases.However,traditional non-degradable occluders made of metal alloys will permanently exist in the body,resulting in thrombosis,valve damage,hemolysis,arrhythmia,or other complications.The biodegradable PFO occluder developed by Shanghai Mallow Medical Instrument Co.,Ltd.,China can be fully absorbed and degrade into nontoxic ingredients,reducing postoperative complications.Objectives:To study the safety and efficacy of biodegradable PFO occluders in treating PFO.Methods:This single-center clinical trial collected 30 patients treated with a biodegradable PFO occluder.The follow-up period lasted 12 months to analyze the echocardiographic characteristics and headache relief through HIT-6 scores.Results:The immediate success rate was 100%,with no intraoperative severe occlusion-related complications.The contrast transcranial Doppler(cTCD)at 12 months showed that all patients’right-to-left shunts(RLS)were grade I or 0 with no serious postoperative complications,indicating the overall success rate was 100%.The biodegradable PFO occluder mostly degraded six months after the occlusion.Conclusion:PFO closure with a Mallow biodegradable occluder is safe and effective and has no severe complications. | Xingbang Li Xuan Zheng Bowen Jin Yunyan Li Yongyu Shao Xiaoxian Deng Dingyang Li Shanshan Li Hongmei Zhou Jie Zhang Xianya Zhang Qunshan Shen Gangcheng Zhang | 2023 | Congenital Heart Disease2023，18，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员